Unternehmen HBL - Hadasit Bio-Holdings Ltd TEL AVIV STOCK EXCHANGE
Aktien
HDST
IL0010954050
HDST
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 20.09.15 |
Tamar Raz
CHM | Chairman | 60 | 18.05.14 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 31.08.15 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 29.07.18 |
Erez Meltzer
BRD | Director/Board Member | 66 | 05.07.16 |
Orit Stav
BRD | Director/Board Member | 53 | 01.11.17 |
Tamar Raz
CHM | Chairman | 60 | 18.05.14 |
Merav Kaye
BRD | Director/Board Member | 50 | 28.09.14 |
Asher Elhayany
BRD | Director/Board Member | 71 | 26.12.22 |
Director/Board Member | 58 | 18.07.21 | |
Yuval Adar
BRD | Director/Board Member | 51 | 19.07.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 11 088 522 | 2 772 493 ( 25,00 %) | 0 | 25,00 % |
Unternehmenskontakt
HBL- Hadasit Bio-Holdings Ltd.
Jerusaelm Bio-Park Hadassah Ein-Kerem Campus
91120, Jerusalem
+
http://www.hbl.co.ilSektor
% 1. Jan. | Kap. | |
---|---|---|
+9.30% | 45.97 Mrd. | |
+52.73% | 43.93 Mrd. | |
+7.15% | 42.34 Mrd. | |
-8.78% | 28.27 Mrd. | |
+18.68% | 27.18 Mrd. | |
-21.92% | 19.44 Mrd. | |
+14.62% | 13.83 Mrd. | |
+31.85% | 12.4 Mrd. | |
+4.47% | 11.45 Mrd. |